Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT04044768 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial
NCT04044768 · ClinicalTrials.gov record · last posted 2026-08-26

Spearhead 1 Study in Subjects With Advanced Synovial Sarcoma or Myxoid/Round Cell Liposarcoma

StatusActive, Not Recruiting
PhasePhase 2
Started2019-08-13
View on ClinicalTrials.gov ↗
from the ClinicalTrials.gov record
This is a study to investigate the efficacy and safety of ADP-A2M4 in HLA-A\*02 eligible and MAGE-A4 positive subjects with metastatic or inoperable (advanced) Synovial Sarcoma (Cohort 1, 2 and 3 ) or MRCLS (Cohort 1) .

Amendment record 26 amendments on the ClinicalTrials.gov record

This ClinicalTrials.gov record has been amended 26 times since 2019-08-01; most recent amendment 2026-02-05. DataLookout shows field-level changes from the day a trial enters its daily monitoring; earlier amendments are counted here from the ClinicalTrials.gov version history. See every version on ClinicalTrials.gov ↗

2024-09-03
Status change RecruitingActive, Not Recruitingv24
2019-08-08
Status change Not Yet RecruitingRecruitingv1
Trial Details
NCT Number NCT04044768
Lead Sponsor USWM CT, LLC
Conditions Synovial Sarcoma, Myxoid Liposarcoma
Enrollment 52 participants
Start Date 2019-08-13
Primary Completion 2021-08-29 (estimated)
Study Completion 2038-04-01 (estimated)
Updated on ClinicalTrials.gov 2026-08-26